Hepatitis

  • Most Topular Stories

  • Hepatitis A Cluster in Alabama

    Hepatitis Blog
    Bill Marler
    27 Sep 2014 | 9:29 am
    The Alabama Department of Public Health is investigating three cases of hepatitis A in Clarke County in southwest Alabama. The department says two of the cases involve people who have a history of international travel. The health department says signs of hepatitis A appear 15 to 50 days after exposure and commonly include mild fever, loss of appetite, nausea, vomiting and tiredness. The disease varies in severity from about two weeks to six weeks or more. The department says casual contact, such as at an office or school, does not transmit the virus. The risk increases when people are in…
  • Approach and Management of Patients with Chronic Hepatitis B and C During the Course of Inflammatory Bowel Disease

    MedWorm: Hepatitis B
    23 Oct 2014 | 8:23 pm
    Abstract:Inflammatory bowel disease and chronic viral hepatitis are 2 distinct but common conditions throughout the world. Mostly, both need life-long follow-up. Since immunosuppressive drugs remain corner stones of inflammatory bowel disease management, one should be aware of the concomitant presence of chronic viral hepatitis in such patients to prevent serious (even fatal) outcomes. Recently, new treatment options have become available in the treatment of both inflammatory bowel disease and chronic viral hepatitis. In this review, we have discussed and summarized current treatment and…
  • What Are the Common Tests That Help Diagnose...

    About.com Hepatitis: What's Hot Now
    hepatitis.guide@about.com
    24 Oct 2014 | 4:14 am
    Doctors use several methods to help diagnose hepatitis. These include blood tests for enzymes and antibodies and more advanced testing like biopsy and magnetic resonance imaging.
  • What Is a "Pegylated" Drug?

    About.com Hepatitis: Most Popular Articles
    24 Oct 2014 | 5:47 am
    Pegylated interferon is a powerful chronic hepatitis therapy.
  • Dropout Rate for Taking Sovaldi: 400% Higher Than Observed in Clinical Trials

    Hepatitis Central
    The Editors at Hepatitis Central
    7 Oct 2014 | 6:47 am
    CVS: One In 12 Hepatitis C Patients Not Adhering To $1,000/Day Pill By David Kroll, 9/17/14 Over 8 percent of hepatitis C patients taking Sovaldi (sofosbuvir; Gilead) are failing to complete their full, 12-week course of drug therapy, a dropout rate roughly four times that observed in clinical trials. By discontinuing the drug, shown to have a 90+% cure rate, these patients (and their insurance providers) are incurring health care costs of $28,000 or $56,000, without knowing if they are rid of the virus. Continue reading this entire article:…
 
  • add this feed to my.Alltop

    About.com Hepatitis: What's Hot Now

  • What Are the Common Tests That Help Diagnose...

    hepatitis.guide@about.com
    24 Oct 2014 | 4:14 am
    Doctors use several methods to help diagnose hepatitis. These include blood tests for enzymes and antibodies and more advanced testing like biopsy and magnetic resonance imaging.
  • Viral Hepatitis and the Five Viruses that Cause...

    hepatitis.guide@about.com
    24 Oct 2014 | 4:14 am
    Viral hepatitis is a liver disease that is caused by exposure to one of the five hepatitis viruses. Each virus is named after a letter of the alphabet, hepatitis A through E. Though other viruses can cause hepatitis, only five are considered hepatitis viruses.
  • Why Is Jaundice the Telltale Sign of Hepatitis A?

    hepatitis.guide@about.com
    24 Oct 2014 | 4:14 am
    Hepatitis A is a very contagious disease that's spread by a virus. However, there is good news. It's rarely fatal and doesn't cause chronic disease. Plus, if you have it once, you'll never get it again.
  • Organs of the Digestive System

    hepatitis.guide@about.com
    24 Oct 2014 | 4:14 am
    Hepatitis.
  • Hepatitis C Treatment

    hepatitis.guide@about.com
    24 Oct 2014 | 4:14 am
    Hepatitis C treatment with peginterferon and ribavirin delay or prevent complications like cirrhosis and liver cancer, but have powerful side effects and doesn't work well for some virus genotypes.
 
  • add this feed to my.Alltop

    Hepatitis Central

  • Dropout Rate for Taking Sovaldi: 400% Higher Than Observed in Clinical Trials

    The Editors at Hepatitis Central
    7 Oct 2014 | 6:47 am
    CVS: One In 12 Hepatitis C Patients Not Adhering To $1,000/Day Pill By David Kroll, 9/17/14 Over 8 percent of hepatitis C patients taking Sovaldi (sofosbuvir; Gilead) are failing to complete their full, 12-week course of drug therapy, a dropout rate roughly four times that observed in clinical trials. By discontinuing the drug, shown to have a 90+% cure rate, these patients (and their insurance providers) are incurring health care costs of $28,000 or $56,000, without knowing if they are rid of the virus. Continue reading this entire article:…
  • The Affordability of Sovaldi

    Nicole Cutler L.Ac.
    1 Oct 2014 | 12:29 pm
    Sovaldi is currently one of the best medications approved to defeat the tenacious Hepatitis C virus. With a price tag of $1,000 per pill, this drug’s cost is probably its biggest caveat. The World Health Organization estimates that 130 million people have been infected with Hepatitis C, and many of those are far from able to afford the $84,000 needed for Sovaldi’s twelve weeks of treatment. However, the price of $1,000 per pill does not seem to apply to everyone. Besides differences in what U.S. health insurers will cover, generic licensing of Sovaldi in developing countries will…
  • Similar, But Different – Hepatitis C Co-Infection and Superinfection

    Nicole Cutler L.Ac.
    16 Sep 2014 | 7:40 am
    Infecting an estimated 150 million people worldwide, the Hepatitis C virus has proven itself to be a tenacious foe. A leading cause of chronic liver disease, cirrhosis and liver cancer, there is not yet a vaccine to prevent Hepatitis C, and experts believe many are unknowingly infected. Once diagnosis has been made, treatment is arduous and may be ineffective for 10 to 50 percent who begin a cocktail of potent medications. Battling one strain of hepatitis is hard enough, but some people have more than one infection. As a blood borne virus, Hepatitis C is spread via blood-to-blood contact.
  • Say it Ain’t So…New Hep C Drug to Surpass $84,000

    The Editors at Hepatitis Central
    15 Sep 2014 | 9:27 am
    Gilead to raise price for new hepatitis C drug above $84,000 By Deena Beasley September 12, 2014 (Reuters) – The next generation version of Gilead Sciences Inc’s $84,000 hepatitis C drug, already under fire for its record-breaking costs, is going to be even more expensive. Gregg Alton, Gilead’s executive vice president of corporate and medical affairs, declined to give an exact price for the new medicine, the first all-oral treatment for the virus which is expected to launch next month. Continue reading this entire article:…
  • How Quickly Can HCV be Eradicated?

    The Editors at Hepatitis Central
    11 Sep 2014 | 9:48 am
    Telaprevir Treatment Decays Hepatitis C Virus Faster in Blood than Liver By Catherine Kolonko | September 10, 2014 A recent study found that the hepatitis C virus decays during treatment with telaprevir faster in the bloodstream than it does in the liver, a discovery that could help pinpoint how long a patient needs to take medicine to rid the virus from the body. The study was conducted by Andrew Talal, MD, and other researchers at Weill Cornell Medical College in New York City and the findings published in Hepatology. It was the first time scientists traced in real time how the drug…
 
  • add this feed to my.Alltop

    Hepatitis News

  • 37 miss UPDF entry over Hepatitis B infection

    24 Oct 2014 | 9:57 am
    The group that had passed all the other subjected tests had their progress cut short on Thursday evening by the infectious illness of the liver caused by the hepatitis B virus At least 37 applicants that turned up for recruitment into the army have been turned away for testing positive with Hepatitis B. The group that had passed all the other subjected tests had their progress cut short on Thursday evening by the infectious illness of the liver caused by the hepatitis B virus . Other tests conducted include, the physical fitness test, the HIV test, Pregnancy test, other clinical illnesses and…
  • New Hepatitis C drug could be available shortly

    24 Oct 2014 | 6:00 am
    Mr Varadkar said the aim is to have the programme available for people who are at risk of irreversible liver damage An early access programme to a new drug for up to 200 people with Hepatitis C could be operational within a few weeks, but subject to an agreement with the drug makers on price, according to Minister for Health, Leo Varadkar. Mr Varadkar said the aim is to have the programme available for people with the virus, who are at risk of irreversible liver damage, if they do not get treatment soon.
  • UPDATE 1-Insurer Epic offers Ebola cover for U.S. health and emergency workers

    24 Oct 2014 | 2:08 am
    U.S. insurer Epic said on Thursday it had launched Ebola indemnity cover for U.S. healthcare and emergency workers. At least 4,877 people have died in the world's worst recorded outbreak of Ebola, mainly in West Africa.
  • Prediction of fibrosis progression in chronic viral hepatitis.

    23 Oct 2014 | 6:42 pm
    Prediction of liver fibrosis progression has a key role in the management of chronic viral hepatitis, as it will be translated into the future risk of cirrhosis and its various complications including hepatocellular carcinoma. Both hepatitis B and C viruses mainly lead to fibrogenesis induced by chronic inflammation and a continuous wound healing response.
  • Foodborne illness declines in Australia

    23 Oct 2014 | 2:49 pm
    Foodborne illness caused an estimated 4.1 million illnesses, 30,600 hospitalizations, and 60 deaths in 2010. The figure for illnesses circa 2000 was 4.3 million.
 
  • add this feed to my.Alltop

    Hepatitis Blog

  • Hepatitis A Cluster in Alabama

    Bill Marler
    27 Sep 2014 | 9:29 am
    The Alabama Department of Public Health is investigating three cases of hepatitis A in Clarke County in southwest Alabama. The department says two of the cases involve people who have a history of international travel. The health department says signs of hepatitis A appear 15 to 50 days after exposure and commonly include mild fever, loss of appetite, nausea, vomiting and tiredness. The disease varies in severity from about two weeks to six weeks or more. The department says casual contact, such as at an office or school, does not transmit the virus. The risk increases when people are in…
  • 165 Sick with Hepatitis A Linked to Townsend Farms Organic Antioxidant Blend

    Bill Marler
    25 Sep 2014 | 9:52 pm
    165 people were confirmed to have become ill from hepatitis A after eating ‘Townsend Farms Organic Antioxidant Blend’ in 10 states: Arizona (24), California (80), Colorado (29), Hawaii (8), New Hampshire (1), New Jersey (1), New Mexico (11), Nevada (6), Utah (3), and Wisconsin (2). [Note: The cases reported from Wisconsin resulted from exposure to the product in California, the cases reported from New Hampshire reported fruit exposure during travel to Nevada, and the case reported in New Jersey was a household contact of a confirmed case from Colorado.] Eight of the confirmed cases were…
  • Whataburger Linked to Hepatitis A Scare

    Bill Marler
    21 Aug 2014 | 9:12 pm
    Austin Texas health officials are alerting the public about possible hepatitis A exposure at a Whataburger in Central Austin. A restaurant employee there at the 2800 Guadalupe St. location has been diagnosed with the hepatitis A virus. Hepatitis A is a contagious liver disease that is usually spread when a person ingests something that has been contaminated with the feces of an infected person, including contaminated food or water. Signs and symptoms of hepatitis A can include the following Fever Fatigue Loss of appetite Nausea Vomiting Abdominal discomfort Dark urine Clay-colored bowel…
  • Another Reason for Hepatitis A Vaccines – Your Restaurant Remains Closed

    Bill Marler
    19 Jul 2014 | 5:09 am
    Tortilla Marissa’s, a Mexican restaurant in Fort Collins, CO, will not reopen until August 9 because of the Hepatitis A scare that the restaurant faced at the end of June, according to the Coloradoan. The Larimer County Health Department has advised the owners to keep the restaurant closed that long due to the virus’ relatively long incubation period, which averages 28 days but can last up to 50 days in some cases. The restaurant originally closed on June 27, a day after an employee tested positive for the virus, which has a high risk of being spread when an infected person handles…
  • Another Hepatitis A Scare: Tortilla Marissa’s Restaurant Worker

    Bill Marler
    28 Jun 2014 | 7:46 am
    The Larimer County Department of Health and Environment is advising the public about a possible exposure to hepatitis A virus at the Tortilla Marissa’s restaurant located at 2635 S. College Avenue in Fort Collins. A food worker employed at Tortilla Marissa has tested positive for hepatitis A, a disease that might be passed to others through food directly handled by the employee before any symptoms appeared.  The restaurant is cooperating fully in the investigation and has agreed to voluntarily close until approved by the Department to reopen.  The risk of transmission to others occurred…
  • add this feed to my.Alltop

    HCV New Drug Research

  • Hepatitis C Weekend Reading: "Not without a fight Kim!" A Mothers Story

    24 Oct 2014 | 6:10 pm
    Good day everyone, hope you all have a safe and enjoyable weekend.Tomorrow I begin a new chapter in my life, I'm moving across the state, only five minutes from my children and grandchildren. Here comes trouble!I am so grateful to be healthy, after watching Kim Bossley share her story today on Second Opinion, I was reminded this morning of just how fortunate I am. * I successfully treated HCV soon after being diagnosed in 2000 Summary  Kim's Story and The Bonnie Morgan FoundationKim's story begins with her mother, Bonnie Morgan, who suffered with kidney…
  • Hepatitis C Virus Infection as a Traumatic Experience

    24 Oct 2014 | 2:02 pm
    Hepatitis C Virus Infection as a Traumatic Experience Mychelle Morais-de-Jesus, Renato Daltro-Oliveira, Karine Miranda Pettersen, Adriana Dantas-Duarte, Luciana Di-Domizio Amaral, Patrícia Cavalcanti-Ribeiro, Carlos Teles Santos, Maria Isabel Schinoni, Liana R. Netto, Lucas Araújo-de-Freitas, Raymundo Paraná, Ângela Miranda-Scippa, Karestan C. Koenen, Lucas C. Quarantini mail Published: October 23, 2014 •DOI: 10.1371/journal.pone.0110529AbstractObjectiveThe purpose of this study was to evaluate whether individuals consider their HCV infection to be a potentially traumatic experience.
  • AHF to Gilead: Do Your Patriotic Duty and Lower Hep. C Drug Prices for Veterans

    24 Oct 2014 | 1:17 pm
    AHF to Gilead: Do Your Patriotic Duty and Lower Hep. C Drug Prices for VeteransAIDS organization calls out Gilead Sciences for offering its Hepatitis C drugs Sovaldi and Harvoni to India and other countries for $900, yet charging the U.S. Department of Veteran Affairs nearly $50,000 per veteran. With rates of Hepatitis C nearly five-times higher among veterans than in the general population, Sovaldi and Harvoni are expected to cost the VA over $1.3 billion over the next two years.WASHINGTON--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), the world’s largest AIDS organization and an…
  • Multi-part series: Opioid Addiction Crisis Fuels Another: Hep C

    24 Oct 2014 | 12:28 pm
    Related:Multi-part series on hepatitis CPart 1At The Crossroads, Part 1: A Tale Of Two EpidemicsOpioid Addiction Crisis Fuels Another: Hep CBy KRISTIN GOURLAYUnforeseen consequenceThere's been a surge in new users of injection drugs, mainly heroin... Along with it, the CDC reports a surge of new cases of hepatitis C... I spoke with the head of the CDC's division of viral hepatitis, Dr. John Ward, who told me that epidemiologists are still trying to get a handle on this surge. But he called it a new epidemic:“We have been concerned for several years about the rising number of reports of new…
  • More HCV screening, better treatments should curb infection rate, researchers find

    24 Oct 2014 | 12:18 pm
    Model Predicts Sharp Decline in Hep C BurdenOctober Issue:Gastroenterology & Endoscopy News by Monica J. SmithMore screening, better treatments should curb infection rate, researchers findby Monica J. SmithThe public health burden posed by chronic infection with the hepatitis C virus (HCV), which claimed more lives in 2007 than HIV and is associated with an annual cost in the United States of about $6.5 billion, may be greatly diminished by 2036, according to a recently published computer simulation study (Ann Intern Med 2014;161:170-180).Significant changes have occurred since the…
 
Log in